 | iBio, Inc. | |||
| ASE : IBIO || Location: United States | ||||
$1.76+0.04 (+2.33%) |
0.06 M | 1.72 - 1.8 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 0.184 M |
| March 28, 2024 | 0.162 M |
| March 15, 2024 | 0.059 M |
| Feb. 29, 2024 | 0.107 M |
| Feb. 15, 2024 | 0.014 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/30/2023 | -8.36 | 5.20 | 162.17% |
| 12/31/2022 | -2.03 | -3.42 | -68.49% |
| 09/30/2022 | -1.89 | -2.05 | -8.35% |
| 06/30/2022 | -2.12 | -1.96 | 7.50% |
| 03/31/2022 | -1.37 | -1.50 | -9.50% |
IBIO Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 8.611M | Shares Float | 2.653M |
| Short Float | 0.184M | Market Cap | 14.81M |
| Institution ownership | 26.90% | Insider ownership | 0.178% |
| Earnings Date | 05/13/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -15.25 | Forward EPS | -2.40 |